Kymera Therapeutics
KYMR
#3656
Rank
A$4.47 B
Marketcap
$69.16
Share price
3.38%
Change (1 day)
127.42%
Change (1 year)

Kymera Therapeutics (KYMR) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.21 Billion

According to Kymera Therapeutics's latest financial reports the company's total liabilities are A$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kymera Therapeutics - Total liabilities on balance sheet (from 2019 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.26 B59.83%
2022-12-31A$0.16 B-17.71%
2021-12-31A$0.20 B-23.69%
2020-12-31A$0.26 B-3.14%
2019-12-31A$0.27 B144.44%
2018-12-31A$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$40.75 M-81.32%๐Ÿ‡บ๐Ÿ‡ธ USA